Searched for
STRIDES PHARMA ACQUISITION
Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa businessStrides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, wit...- Strides Pharma Science to acquire Endo's manufacturing facility in US along with basket of ANDAsStrides said the facility at Chestnut Ridge, New York has an annual capacity of 2 billion units across semi- solids, liquids, nasal sprays ...
- Strides Pharma buys 70% in Swiss companyThe acquisition further strengthens Strides' footprint in continental Europe.
- Strides bags majority stake in South Africa's TrinityStrides Pharma Asia Pte, which is a wholly-owned subsidiary of Strides Shasun, to acquire 55% stake for a cash consideration of Rs 27.5 cr.
- Arrow Pharma acquires Australian operations of Amneal PharmaUnder the terms of the agreement, Arrow Pharmaceuticals will acquire 100 per cent of the issued capital of Amneal Pharmaceutical Pty Ltd Au...
- Strides Shasun acquires 3 brands of Moberg PharmaDrug firm Strides Shasun has completed the acquisition of three brands of Sweden-based Moberg Pharma.
- Strides Shasun to acquire three brands of Moberg Pharma for $10 million"Recent acquisitions have enabled Strides Shasun build an emerging OTC (over-the-counter) franchise both in regulated and emerging markets,...
- Strides Shasun gets CCI nod to buy 7 brands of Johnson and JohnsonStrides will buy Johnson and Johnson's seven brands in dermatology, anti-emetic and pain management segments.
- Strides Shasun gets CCI nod to buy Sun Pharma's two divisionsStrides Shasun today got CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.
- Strides Arcolab buys local J&J brands, picks majority stake in MedispanIn an announcement on the NSE Wednesday, Strides said the brand portfolio includes Otogesic eardrops, Ehnorub ointment and Stugil tablets.
- Strides Arcolab gains as company acquires CNS divisions of erstwhile RanbaxyThe agreement involves transfer of these two marketing divisions, along with employees to Strides for a consideration of Rs 165 crore.
- Strides Arcolab to get product pipeline developed by AspenStrides Arcolab has said its deal with Aspen Pharmacare to buy the latter's Australia assets will help the Indian drug company rebuild its ...
- Strides Arcolab surges as company to buy some Australia drug assets from South Africa's Aspen Pharmacare; ends 8% higherStrides Arcolab today said it will acquire South Africa's Aspen Pharmacare's portfolio of branded and generics products in Australia for ab...
- Strides Arcolab set to acquire Shasun Pharma in an all-stock dealShareholders of Chennai-based Shasun Pharma will receive five equity shares of Strides for every 16 equity shares they hold in the company.
- Strides to pick up 74% stake in Bafna through a special purpose vehicleLast week, the company invested in US-based research company, Oncobiologics, which is working to bring key biosimilar drugs to the Indian m...
- Zydus Cadila in talks to buy Strides Arcolab' Rs 70-crore India generic businessZydus Cadila is in early stages of talks to acquire Bangalore-based Strides Arcolab's Rs 70-crore domestic generic business.
- Strides Arcolab: Growth must for stock price riseThe acquisition of Campos facility in Brazil with relevant products and intellectual properties (IPs) is yet another positive development f...
- Strides to acquire Aspen's Brazilian facility for $75 mnPharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Br...
- Strides eyes M&As for speciality pharma, R&DI-bankers, acting on behalf of Strides, have signalled M&A interest on part of the promoter group for its speciality pharma and R&D units.
- Strides, Aspen ink four JVs to strengthen niche armsIt is raining deals at Bangalore-based mid-sized pharma player Strides Arcolab.
Load More
